Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS 2006. Norovirus classification and proposed strain nomenclature. Virology 346: 312-323. Zheng DP, Widdowson MA, Glass RI, Vinjé J 2010.

A top doctor has revealed the four foods she refuses to touch while dining out, for fears of contamination that could cause life-threatening infections.

Norovirus GII.17 accounted for < 10% of outbreaks in the US 2022-23 season, but rose to 75% during the 2024-25 season, passing the number of GII.4 outbreaks.

Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.